DaCapo Brainscience Case Study
Making Progress When Every Hour (and Dollar) Counts
Led by serial entrepreneur and biotech industry veteran, Katrine Bosley, DaCapo Brainscience is focused on creating novel medicines to address progression in neurodegenerative diseases, specifically Parkinson's Disease. DaCapo is dedicated to developing breakthrough therapies that restore brain function by reactivating dormant neural repair mechanisms.
Challenge
When neuroscience visionary Vik Khurana approached Katrine Bosley with the concept behind DaCapo, she didn't need a crystal ball to see the challenges ahead. As a seasoned biotech founder, she knew the funding landscape was becoming increasingly rocky—"for better or for worse," as she put it.
But here was the classic scientific startup Catch-22: they needed to replicate their promising academic findings to attract investors yet needed funding to secure the lab space where that replication could happen. Every biotech entrepreneur knows this particular dance all too well.
Time wasn't just money—it was everything. The induced pluripotent stem cell (iPSC) models central to their work demanded patience and precision; there were simply no shortcuts available. Setting up a lab from scratch would burn through precious weeks they couldn't afford to lose. How do you invest time and resources when you're short on both? That was the puzzle DaCapo needed to solve.
Solution
Fortunately, Katrine's years navigating Cambridge's biotech ecosystem had given her some valuable insights—including knowing when to call on LabCentral. By launching DaCapo in this ready-to-use environment, they sidestepped the typical startup delays.
No waiting for equipment deliveries. No troubleshooting temperamental instruments. No permit applications or waste management protocols to figure out. LabCentral had already handled these essentials, creating a frictionless entry that allowed DaCapo to focus on what mattered most: getting their cells growing, their experiments running, and their data flowing.
This head start meant they could move swiftly from concept to concrete results—exactly what they needed to make their case to potential investors and build the team that would carry their neural repair breakthroughs forward.
Results
Science
“LabCentral provided us with the tools we needed to get to work quickly. We knew we needed to start our research early because there was a real time to it that you couldn’t shortcut. That’s a lot of what we do here, we’re always in that tissue culture room.”
Katrine Bosley
Founding CEO
DaCapo Brainscience
Business
“Every time I pitch to investors, I have a confidence in what we're saying because we had the time and space to focus on repeating our findings. And there’s just no substitute for that.”
Katrine Bosley
Founding CEO
DaCapo Brainscience
People
“The first, second and third thing I would say about the LabCentral community, is that it’s incredibly available to help. We have all been there and frankly, we all root for each other’s success.”
Katrine Bosley
Founding CEO
DaCapo Brainscience
